| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| hypoxia-inducible factor 1 alpha subunit | 7 | 0 | 0 | 7 |
| RAR-related orphan receptor gamma | 17 | 0 | 0 | 17 |
| GLI family zinc finger 3 | 15 | 0 | 0 | 15 |
| AR protein | 20 | 0 | 0 | 20 |
| aldehyde dehydrogenase 1 family, member A1 | 14 | 0 | 0 | 14 |
| retinoic acid nuclear receptor alpha variant 1 | 14 | 0 | 0 | 14 |
| retinoid X nuclear receptor alpha | 12 | 0 | 0 | 12 |
| estrogen nuclear receptor alpha | 20 | 0 | 0 | 20 |
| peroxisome proliferator-activated receptor delta | 9 | 0 | 0 | 9 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 9 | 0 | 0 | 9 |
| activating transcription factor 6 | 4 | 0 | 0 | 4 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 9 | 0 | 0 | 9 |
| Histone H2A.x | 8 | 0 | 0 | 8 |
| thyroid hormone receptor beta isoform a | 5 | 0 | 0 | 5 |
| heat shock protein beta-1 | 6 | 0 | 0 | 6 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 16 | 0 | 0 | 16 |
| lamin isoform A-delta10 | 13 | 0 | 0 | 13 |
| Voltage-dependent calcium channel gamma-2 subunit | 9 | 0 | 0 | 9 |
| Glutamate receptor 2 | 9 | 0 | 0 | 9 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 2 | 0 | 5 |
| Free fatty acid receptor 3 | 0 | 0 | 1 | 1 |
| Free fatty acid receptor 2 | 0 | 1 | 1 | 2 |
| Tyrosine-protein kinase Lck | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase Fyn | 0 | 0 | 1 | 1 |
| Fibrinogen C domain-containing protein 1 | 0 | 1 | 0 | 1 |
| Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
| acid sphingomyelinase | 1 | 0 | 0 | 1 |
| TDP1 protein | 17 | 0 | 0 | 17 |
| Smad3 | 2 | 0 | 0 | 2 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 10 | 0 | 0 | 10 |
| G | 5 | 0 | 0 | 5 |
| cytochrome P450 2D6 | 5 | 0 | 0 | 5 |
| IDH1 | 7 | 0 | 0 | 7 |
| chromobox protein homolog 1 | 9 | 0 | 0 | 9 |
| NEDD8-activating enzyme E1 regulatory subunit isoform a | 0 | 1 | 0 | 1 |
| NEDD8-conjugating enzyme Ubc12 | 0 | 1 | 0 | 1 |
| nuclear receptor ROR-gamma isoform 1 | 6 | 0 | 0 | 6 |
| geminin | 13 | 0 | 0 | 13 |
| histone acetyltransferase KAT2A isoform 1 | 4 | 0 | 0 | 4 |
| ATP-binding cassette sub-family C member 3 | 0 | 11 | 0 | 11 |
| Multidrug resistance-associated protein 4 | 0 | 11 | 0 | 12 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 2 | 0 | 2 | 1 | 3 |
| Bile salt export pump | 0 | 14 | 0 | 14 |
| Interferon beta | 6 | 0 | 0 | 6 |
| HLA class I histocompatibility antigen, B alpha chain | 5 | 0 | 0 | 5 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 7 | 1 | 8 |
| Alpha-2C adrenergic receptor | 0 | 7 | 1 | 8 |
| Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-1D adrenergic receptor | 0 | 3 | 0 | 3 |
| Alpha-1A adrenergic receptor | 0 | 2 | 1 | 3 |
| Alpha-1B adrenergic receptor | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 6 | 0 | 4 | 0 | 4 |
| Spike glycoprotein | 6 | 1 | 1 | 8 |
| Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
| Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 5 | 0 | 0 | 5 |
| Canalicular multispecific organic anion transporter 1 | 0 | 11 | 0 | 11 |
| cytochrome P450 2C9, partial | 5 | 0 | 0 | 5 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 10 | 0 | 0 | 10 |
| Chain A, Beta-lactamase | 3 | 0 | 0 | 3 |
| Chain A, 2-oxoglutarate Oxygenase | 8 | 0 | 0 | 8 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
| DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
| DNA polymerase iota isoform a (long) | 7 | 0 | 0 | 7 |
| urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
| plasminogen precursor | 2 | 0 | 0 | 2 |
| urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
| DNA polymerase kappa isoform 1 | 6 | 0 | 0 | 6 |
| Bile salt export pump | 0 | 1 | 0 | 1 |
| Beta-lactamase SHV-1 | 0 | 0 | 0 | 2 |
| Beta-lactamase SHV-1 | 0 | 0 | 0 | 2 |
| Cytochrome P450 2C9 | 0 | 3 | 0 | 3 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 0 | 0 | 2 |
| Solute carrier family 15 member 1 | 0 | 2 | 0 | 2 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2J2 | 0 | 3 | 0 | 3 |
| B2 metallo-beta-lactamase | 0 | 0 | 0 | 2 |
| Solute carrier family 15 member 2 | 0 | 2 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Solute carrier family 15 member 2 | 0 | 2 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| thioredoxin reductase | 9 | 0 | 0 | 9 |
| phosphopantetheinyl transferase | 7 | 0 | 0 | 7 |
| NFKB1 protein, partial | 2 | 0 | 0 | 2 |
| GLS protein | 5 | 0 | 0 | 5 |
| thyroid stimulating hormone receptor | 7 | 0 | 0 | 7 |
| alpha-galactosidase | 1 | 0 | 0 | 1 |
| euchromatic histone-lysine N-methyltransferase 2 | 11 | 0 | 0 | 11 |
| cytochrome P450 2C19 precursor | 3 | 0 | 0 | 3 |
| flap endonuclease 1 | 6 | 0 | 0 | 6 |
| muscarinic acetylcholine receptor M1 | 3 | 0 | 0 | 3 |
| lethal factor (plasmid) | 4 | 0 | 0 | 4 |
| Cytochrome P450 3A4 | 0 | 3 | 1 | 5 |
| Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 1 | 0 | 2 |
| Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
| Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
| ATP-dependent phosphofructokinase | 6 | 0 | 0 | 6 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 5 | 0 | 0 | 5 |
| Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
| Chain A, HADH2 protein | 8 | 0 | 0 | 8 |
| Chain B, HADH2 protein | 8 | 0 | 0 | 8 |
| GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
| ras protein, partial | 0 | 0 | 1 | 1 |
| interleukin 8 | 5 | 0 | 0 | 5 |
| hypothetical protein, conserved | 3 | 0 | 0 | 3 |
| EWS/FLI fusion protein | 8 | 0 | 0 | 8 |
| glucocorticoid receptor [Homo sapiens] | 15 | 0 | 0 | 15 |
| estrogen-related nuclear receptor alpha | 16 | 0 | 0 | 16 |
| glucocerebrosidase | 5 | 0 | 0 | 5 |
| Rac1 protein | 0 | 0 | 1 | 1 |
| cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
| Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 5 | 0 | 0 | 5 |
| Prostaglandin-H2 D-isomerase | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 3 | 0 | 3 |
| Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 4 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 4 |
| Epidermal growth factor receptor | 0 | 4 | 0 | 4 |
| Carbonic anhydrase 1 | 0 | 5 | 0 | 6 |
| Carbonic anhydrase 2 | 0 | 5 | 0 | 6 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Integrin beta-3 | 1 | 1 | 0 | 2 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 4 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
| Integrin alpha-IIb | 1 | 1 | 0 | 2 |
| Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
| Adenosine receptor A1 | 0 | 2 | 0 | 3 |
| Adenosine receptor A2a | 0 | 2 | 0 | 3 |
| Substance-P receptor | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 2 | 0 | 5 | 1 | 6 |
| Urotensin-2 receptor | 0 | 1 | 0 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-gamma | 7 | 0 | 0 | 7 |
| Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 4 | 2 | 0 | 6 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
| Rho-associated protein kinase 2 | 0 | 2 | 0 | 2 |
| Nicotinate phosphoribosyltransferase | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 1 | 3 |
| Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 3 | 0 | 0 | 3 |
| Chain A, Cruzipain | 5 | 0 | 0 | 5 |
| USP1 protein, partial | 4 | 0 | 0 | 4 |
| Microtubule-associated protein tau | 6 | 0 | 0 | 6 |
| vitamin D3 receptor isoform VDRA | 7 | 0 | 0 | 7 |
| caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| Inositol monophosphatase 1 | 4 | 0 | 0 | 4 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 4 | 0 | 5 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 4 | 0 | 5 |
| nuclear receptor subfamily 1, group I, member 3 | 10 | 0 | 0 | 10 |
| thyroid stimulating hormone receptor | 7 | 0 | 0 | 7 |
| Cellular tumor antigen p53 | 13 | 0 | 0 | 13 |
| Carbonic anhydrase 4 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase | 0 | 3 | 0 | 4 |
| Carbonic anhydrase 15 | 0 | 1 | 0 | 2 |
| Luciferase | 10 | 0 | 0 | 10 |
| progesterone receptor | 9 | 0 | 0 | 9 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 9 | 0 | 0 | 9 |
| cytochrome P450 2C9 precursor | 4 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit pi | 4 | 1 | 0 | 5 |
| Cytochrome P450 1A2 | 0 | 2 | 0 | 2 |
| DNA gyrase subunit B | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 1 | 0 | 2 |
| DNA gyrase subunit A | 0 | 1 | 0 | 3 |
| DNA gyrase subunit B | 0 | 1 | 0 | 3 |
| DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
| DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 2 |
| DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 2 |
| Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
| DNA topoisomerase 2-alpha | 0 | 1 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit delta | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 4 | 1 | 0 | 5 |
| DNA gyrase subunit A | 0 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 4 | 1 | 0 | 5 |
| Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
| Multidrug resistance protein MdtK | 0 | 0 | 1 | 1 |
| Histamine H2 receptor | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 4 | 1 | 0 | 5 |
| DNA gyrase subunit B | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 0 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 5 | 0 | 6 |
| DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
| DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 1 |
| Integrase | 0 | 2 | 0 | 2 |
| GABA theta subunit | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit epsilon | 4 | 1 | 0 | 5 |
| Protein-arginine deiminase type-4 | 0 | 3 | 0 | 3 |
| acetylcholinesterase | 5 | 0 | 0 | 5 |
| estrogen receptor 2 (ER beta) | 9 | 0 | 0 | 9 |
| peroxisome proliferator activated receptor gamma | 10 | 0 | 0 | 10 |
| aryl hydrocarbon receptor | 5 | 0 | 0 | 5 |
| thyroid hormone receptor beta isoform 2 | 11 | 0 | 0 | 11 |
| B2 bradykinin receptor | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 0 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Chymotrypsinogen A | 0 | 2 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Amyloid-beta precursor protein | 1 | 2 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 3 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 0 | 1 |
| Beta-galactosidase | 0 | 1 | 0 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 3 | 0 | 3 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
| Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | 0 | 2 | 0 | 2 |
| PH domain leucine-rich repeat-containing protein phosphatase 2 | 0 | 1 | 0 | 1 |
| Chymotrypsin-C | 0 | 1 | 0 | 1 |
| Deoxycytidine kinase | 0 | 0 | 0 | 1 |
| glp-1 receptor, partial | 6 | 0 | 0 | 6 |
| pregnane X receptor | 3 | 0 | 0 | 3 |
| SMAD family member 2 | 5 | 0 | 0 | 5 |
| SMAD family member 3 | 5 | 0 | 0 | 5 |
| farnesoid X nuclear receptor | 9 | 0 | 0 | 9 |
| pregnane X nuclear receptor | 6 | 0 | 0 | 6 |
| nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
| peripheral myelin protein 22 | 8 | 0 | 0 | 8 |
| Rap guanine nucleotide exchange factor 3 | 3 | 0 | 0 | 3 |
| Estrogen receptor | 0 | 3 | 0 | 3 |
| Glucocorticoid receptor | 0 | 2 | 0 | 2 |
| Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
| Aldo-keto reductase family 1 member B1 | 0 | 4 | 0 | 4 |
| Adenosine receptor A3 | 0 | 2 | 0 | 2 |
| Beta-3 adrenergic receptor | 0 | 2 | 1 | 3 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Alpha-1B adrenergic receptor | 0 | 4 | 0 | 4 |
| Alpha-2B adrenergic receptor | 0 | 5 | 0 | 5 |
| Muscarinic acetylcholine receptor M3 | 0 | 4 | 0 | 4 |
| Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| D(1A) dopamine receptor | 0 | 4 | 0 | 4 |
| Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Sodium-dependent noradrenaline transporter | 0 | 4 | 0 | 4 |
| Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 4 | 0 | 4 |
| Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
| Mu-type opioid receptor | 0 | 3 | 1 | 4 |
| D(3) dopamine receptor | 0 | 4 | 0 | 4 |
| Kappa-type opioid receptor | 0 | 3 | 0 | 3 |
| Alpha-1A adrenergic receptor | 0 | 4 | 0 | 4 |
| ATPase family AAA domain-containing protein 5 | 3 | 0 | 0 | 3 |
| Ataxin-2 | 4 | 0 | 0 | 4 |
| Solute carrier family 22 member 2 | 0 | 0 | 0 | 2 |
| Solute carrier family 22 member 1 | 0 | 2 | 0 | 4 |
| Thromboxane A2 receptor | 0 | 1 | 1 | 2 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 3 | 2 | 5 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 3 | 1 | 4 |
| Prostaglandin F2-alpha receptor | 0 | 2 | 0 | 2 |
| Prostaglandin F2-alpha receptor | 0 | 2 | 2 | 4 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 3 | 2 | 5 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 3 | 1 | 4 |
| Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
| Prostacyclin receptor | 0 | 3 | 1 | 4 |
| Prostaglandin D2 receptor | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 3 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 3 |
| Solute carrier family 22 member 8 | 0 | 2 | 0 | 5 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 2 | 0 | 5 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 2 | 0 | 2 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 3 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 3 |
| regulator of G-protein signaling 4 | 4 | 0 | 0 | 4 |
| prostaglandin E2 receptor EP2 subtype | 1 | 0 | 0 | 1 |
| mitogen-activated protein kinase 1 | 5 | 0 | 0 | 5 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 2 | 0 | 2 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 2 | 0 | 2 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 2 | 0 | 2 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 2 | 0 | 2 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
| Chain A, Uracil Phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| endonuclease IV | 1 | 0 | 0 | 1 |
| Skn7p | 0 | 0 | 0 | 1 |
| ATAD5 protein, partial | 3 | 0 | 0 | 3 |
| Thrombopoietin | 1 | 0 | 0 | 1 |
| nonstructural protein 1 | 3 | 0 | 0 | 3 |
| 67.9K protein | 3 | 0 | 0 | 3 |
| arylsulfatase A | 2 | 0 | 0 | 2 |
| peripheral myelin protein 22 isoform 1 | 3 | 0 | 0 | 3 |
| hemoglobin subunit beta | 1 | 0 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 2 | 0 | 0 | 2 |
| huntingtin isoform 2 | 2 | 0 | 0 | 2 |
| serine/threonine-protein kinase mTOR isoform 1 | 3 | 0 | 0 | 3 |
| Vpr | 2 | 0 | 0 | 2 |
| survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
| muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 3 |
| Thymidylate synthase | 0 | 1 | 0 | 2 |
| Aromatase | 0 | 1 | 0 | 1 |
| HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 1 | 4 |
| Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 1 | 4 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 1 | 4 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 1 | 4 |
| Large neutral amino acids transporter small subunit 1 | 0 | 2 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 1 | 4 |
| Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 1 | 4 |
| Serine racemase | 0 | 1 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 1 | 4 |
| Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
| Purine nucleoside phosphorylase | 0 | 2 | 0 | 2 |
| Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 1 |
| Ricin | 0 | 1 | 0 | 1 |
| 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase | 0 | 0 | 1 | 1 |
| Purine nucleoside phosphorylase | 0 | 0 | 1 | 2 |
| Shiga toxin subunit A | 0 | 1 | 0 | 1 |
| Guanine deaminase | 0 | 0 | 0 | 1 |
| Albumin | 0 | 2 | 1 | 3 |
| Chain E, Fibrin beta chain | 0 | 1 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
| Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
| 15-lipoxygenase, partial | 3 | 0 | 0 | 3 |
| WRN | 1 | 0 | 0 | 1 |
| Mcl-1 | 0 | 1 | 0 | 1 |
| MPI protein | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 0 | 0 | 0 | 1 |
| PPM1D protein | 2 | 0 | 0 | 2 |
| alkaline phosphatase, intestinal | 0 | 0 | 1 | 1 |
| thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
| luciferase | 1 | 0 | 0 | 1 |
| bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
| pyruvate kinase | 1 | 0 | 0 | 1 |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 1 | 0 | 1 |
| CDK5 | 0 | 0 | 0 | 1 |
| serine-protein kinase ATM isoform a | 2 | 0 | 0 | 2 |
| lysosomal alpha-glucosidase preproprotein | 3 | 0 | 0 | 3 |
| major prion protein preproprotein Prp precursor | 0 | 1 | 0 | 1 |
| alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 0 | 1 | 1 |
| cellular tumor antigen p53 isoform a | 2 | 0 | 0 | 2 |
| glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 1 | 0 | 1 |
| intestinal alkaline phosphatase precursor | 0 | 0 | 1 | 1 |
| DNA polymerase beta | 2 | 0 | 0 | 2 |
| serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
| Vif | 0 | 1 | 0 | 1 |
| Tat | 0 | 1 | 0 | 1 |
| cytochrome P450 3A4 isoform 1 | 4 | 0 | 0 | 4 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 0 | 1 | 0 | 1 |
| alkaline phosphatase, germ cell type preproprotein | 0 | 0 | 1 | 1 |
| endoribonuclease toxin MazF | 0 | 0 | 1 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 5 | 0 | 0 | 5 |
| Pyruvate kinase PKM | 0 | 1 | 0 | 1 |
| Endothelin receptor type B | 1 | 0 | 0 | 1 |
| Endothelin-1 receptor | 1 | 0 | 0 | 1 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| hypothetical protein CAALFM_CR05890CA | 0 | 0 | 0 | 1 |
| H3 histone acetyltransferase | 0 | 0 | 0 | 1 |
| large T antigen | 0 | 1 | 0 | 1 |
| Chain A, membrane-associated prostaglandin E synthase-2 | 0 | 1 | 0 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 4 | 0 | 0 | 4 |
| Parkin | 1 | 0 | 0 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 3 | 0 | 0 | 3 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
| cytochrome P450 2D6 isoform 1 | 3 | 0 | 0 | 3 |
| ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
| M-phase phosphoprotein 8 | 3 | 0 | 0 | 3 |
| neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
| Prostaglandin E synthase | 0 | 1 | 0 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
| Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
| Phospholipase A2, major isoenzyme | 0 | 1 | 0 | 1 |
| Procathepsin L | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 1 | 0 | 2 |
| Interleukin-8 | 0 | 1 | 0 | 1 |
| Androgen receptor | 0 | 0 | 1 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 1 | 0 | 2 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 2 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C4 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
| Thromboxane-A synthase | 0 | 1 | 0 | 1 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
| Caspase-1 | 0 | 0 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
| Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
| Aldo-keto reductase family 1 member C3 | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
| C-X-C chemokine receptor type 3 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
| Guanine nucleotide-binding protein G | 3 | 0 | 0 | 3 |
| Prostaglandin D2 receptor | 0 | 2 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 1 |
| Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 2 |
| Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
| Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
| P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
| Cytosolic phospholipase A2 gamma | 0 | 1 | 0 | 1 |
| Prostaglandin D2 receptor 2 | 0 | 1 | 1 | 2 |
| Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
| Platelet-activating factor receptor | 1 | 0 | 0 | 1 |
| Non-structural protein 1 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| streptokinase A precursor | 0 | 0 | 2 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase 1 | 0 | 0 | 0 | 1 |
| Beta-lactamase OXA-10 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase TEM | 0 | 1 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Efflux transporter | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
| Beta-lactamase Toho-1 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Class D beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-b-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase IMP-1 | 0 | 0 | 0 | 1 |
| BlaVIM-1 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 1 |
| Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
| Beta-lactamase VIM-1 | 0 | 0 | 0 | 1 |
| Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
| Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 12 | 0 | 0 | 0 | 1 |
| Plasma kallikrein | 0 | 0 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 3 | 0 | 0 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| 5'-nucleotidase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 6 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 7 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| E3 ubiquitin-protein ligase XIAP | 0 | 1 | 0 | 1 |
| SLC16A10 protein | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
| Monocarboxylate transporter 10 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 0 | 0 | 1 |
| Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 0 | 0 | 1 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
| D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
| Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
| Beta-1 adrenergic receptor | 0 | 0 | 1 | 1 |
| POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-2B adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 0 | 0 | 1 |
| GALC protein | 1 | 0 | 0 | 1 |
| beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
| mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
| Chain A, Hth-type Transcriptional Regulator Ttgr | 0 | 0 | 1 | 1 |
| Chain A, Hth-type Transcriptional Regulator Ttgr | 0 | 0 | 1 | 1 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 2 | 0 | 0 | 2 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
| fibroblast growth factor 22 isoform 1 precursor | 0 | 0 | 0 | 2 |
| serine/threonine-protein kinase 33 isoform a | 0 | 0 | 1 | 1 |
| Monocarboxylate transporter 4 | 0 | 1 | 0 | 1 |
| Pancreatic triacylglycerol lipase | 0 | 1 | 0 | 1 |
| Transthyretin | 0 | 0 | 1 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 1 | 0 | 1 |
| Sodium/glucose cotransporter 1 | 0 | 2 | 0 | 2 |
| Nuclear factor NF-kappa-B p105 subunit | 0 | 1 | 0 | 1 |
| Sodium/glucose cotransporter 2 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 1 | 0 | 1 | 0 | 1 |
| Nuclear factor NF-kappa-B p100 subunit | 0 | 1 | 0 | 1 |
| Transcription factor p65 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 2 | 0 | 1 | 0 | 1 |
| Sodium/hydrogen exchanger 9B2 | 0 | 1 | 0 | 1 |
| Solute carrier family 28 member 3 | 0 | 1 | 0 | 1 |
| Snq2p | 0 | 0 | 0 | 1 |
| Spike glycoprotein | 0 | 1 | 1 | 2 |
| Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
| Transmembrane protease serine 2 | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| Major prion protein | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 3 | 0 | 3 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
| Replicase polyprotein 1a | 0 | 1 | 1 | 2 |
| Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
| Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
| Calmodulin-1 | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Histamine H2 receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1B | 0 | 2 | 0 | 2 |
| Trypanothione reductase | 0 | 2 | 0 | 2 |
| Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
| Histamine H1 receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
| D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Calmodulin | 0 | 0 | 1 | 1 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme 2 | 0 | 1 | 1 | 2 |
| Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 1 | 0 | 2 |
| TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
| heat shock protein 90, putative | 0 | 0 | 0 | 1 |
| Chain A, dATP pyrophosphohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
| Chain B, Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
| Alpha-synuclein | 1 | 1 | 0 | 2 |
| C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
| 90-kda heat shock protein beta HSP90 beta, partial | 0 | 1 | 0 | 1 |
| estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
| tyrosine-protein phosphatase non-receptor type 7 isoform 2 | 0 | 1 | 0 | 1 |
| Dihydroxyacetone phosphate acyltransferase | 0 | 0 | 0 | 1 |
| 30S ribosomal protein S6 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S7 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L15 | 0 | 2 | 0 | 2 |
| Tetracycline resistance protein, class B | 0 | 0 | 0 | 1 |
| 72 kDa type IV collagenase | 0 | 1 | 0 | 1 |
| Stromelysin-1 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L10 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L11 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L7/L12 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L19 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L1 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L20 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L27 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L28 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L29 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L31 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L31 type B | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L32 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L33 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L34 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L35 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L36 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S10 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S11 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S12 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S13 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S16 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S18 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S19 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S20 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S2 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S3 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S4 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S5 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S8 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S9 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L13 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L14 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L16 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L23 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S15 | 0 | 2 | 0 | 2 |
| Multidrug transporter MdfA | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L17 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L21 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L30 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L6 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S14 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S17 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S1 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L18 | 0 | 2 | 0 | 2 |
| Neutrophil collagenase | 0 | 1 | 0 | 1 |
| Collagenase 3 | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L2 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L3 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L24 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L4 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L22 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L5 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S21 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L25 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L36 2 | 0 | 2 | 0 | 2 |
| P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
| Thymidine kinase | 0 | 1 | 0 | 2 |
| Thymidine kinase, cytosolic | 0 | 2 | 0 | 4 |
| Thymidine kinase | 0 | 1 | 0 | 2 |
| Thymidine phosphorylase | 0 | 0 | 0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| Thymidine phosphorylase | 0 | 0 | 0 | 1 |
| Thymidylate kinase | 0 | 1 | 0 | 1 |
| Thymidine kinase, cytosolic | 0 | 0 | 0 | 2 |
| Thymidine kinase | 0 | 0 | 0 | 1 |
| Thymidylate kinase | 0 | 1 | 0 | 1 |
| Thymidine kinase | 0 | 1 | 0 | 2 |
| Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
| Thymidine kinase | 0 | 0 | 0 | 1 |
| Thymidine kinase | 0 | 0 | 0 | 1 |
| Fumarate hydratase | 1 | 0 | 0 | 1 |
| polyprotein | 1 | 0 | 0 | 1 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| Microtubule-associated protein tau | 0 | 2 | 0 | 2 |
| Chain A, PLASMINOGEN | 0 | 0 | 1 | 1 |
| Chain A, PLASMINOGEN | 0 | 0 | 1 | 1 |
| Plasminogen | 0 | 2 | 1 | 3 |
| Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
| twin arginine protein translocation system - TatA protein | 0 | 0 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |